Pre-order Enquiry
Request Free Sample
Covid-19 Impact on Biomarker Market, Global Research Reports 2020-2021
SKU ID : QYR-15647621 | Publishing Date : 11-May-2020 | No. of pages : 95
Detailed TOC of Covid-19 Impact on Biomarker Market, Global Research Reports 2020-2021
1.1 Research Scope1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Biomarker Industry
1.7 COVID-19 Impact: Biomarker Market Trends
2 Global Biomarker Quarterly Market Size Analysis
2.1 Biomarker Business Impact Assessment - COVID-19
2.1.1 Global Biomarker Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Biomarker Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Biomarker Quarterly Market Size, 2019 VS 2020
3.2 By Players, Biomarker Headquarters and Area Served
3.3 Date of Key Players Enter into Biomarker Market
3.4 Key Players Biomarker Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Biomarker Segments, By Type
4.1 Introduction
1.4.1 Consumables
1.4.2 Service
4.2 By Type, Global Biomarker Market Size, 2019-2021
5 Impact of Covid-19 on Biomarker Segments, By Application
5.1 Overview
5.5.1 Diagnostics Development
5.5.2 Drug Discovery and Development
5.5.3 Disease-Risk
5.2 By Application, Global Biomarker Market Size, 2019-2021
5.2.1 By Application, Global Biomarker Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 QIAGEN N.V. (Netherlands)
7.1.1 QIAGEN N.V. (Netherlands) Business Overview
7.1.2 QIAGEN N.V. (Netherlands) Biomarker Quarterly Revenue, 2020
7.1.3 QIAGEN N.V. (Netherlands) Biomarker Product Introduction
7.1.4 QIAGEN N.V. (Netherlands) Response to COVID-19 and Related Developments
7.2 PerkinElmer, Inc. (U.S.)
7.2.1 PerkinElmer, Inc. (U.S.) Business Overview
7.2.2 PerkinElmer, Inc. (U.S.) Biomarker Quarterly Revenue, 2020
7.2.3 PerkinElmer, Inc. (U.S.) Biomarker Product Introduction
7.2.4 PerkinElmer, Inc. (U.S.) Response to COVID-19 and Related Developments
7.3 Merck Millipore (U.S.)
7.3.1 Merck Millipore (U.S.) Business Overview
7.3.2 Merck Millipore (U.S.) Biomarker Quarterly Revenue, 2020
7.3.3 Merck Millipore (U.S.) Biomarker Product Introduction
7.3.4 Merck Millipore (U.S.) Response to COVID-19 and Related Developments
7.4 Bio-Rad Laboratories, Inc. (U.S.)
7.4.1 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
7.4.2 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Quarterly Revenue, 2020
7.4.3 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Product Introduction
7.4.4 Bio-Rad Laboratories, Inc. (U.S.) Response to COVID-19 and Related Developments
7.5 Enzo Biochem, Inc. (U.S.)
7.5.1 Enzo Biochem, Inc. (U.S.) Business Overview
7.5.2 Enzo Biochem, Inc. (U.S.) Biomarker Quarterly Revenue, 2020
7.5.3 Enzo Biochem, Inc. (U.S.) Biomarker Product Introduction
7.5.4 Enzo Biochem, Inc. (U.S.) Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of Figures, Tables and Charts Available in Covid-19 Impact on Biomarker Market, Global Research Reports 2020-2021
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Biomarker Assessment
Table 9. COVID-19 Impact: Biomarker Market Trends
Table 10. COVID-19 Impact Global Biomarker Market Size
Table 11. Global Biomarker Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Biomarker Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Biomarker Market Growth Drivers
Table 14. Global Biomarker Market Restraints
Table 15. Global Biomarker Market Opportunities
Table 16. Global Biomarker Market Challenges
Table 17. By Players, Biomarker Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Biomarker Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Biomarker Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Biomarker Market
Table 21. Key Players Biomarker Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Biomarker Market Size 2019-2021, (US$ Million)
Table 24. Global Biomarker Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Biomarker Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Biomarker Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Biomarker Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Biomarker Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Biomarker Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Biomarker Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Biomarker Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Biomarker Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Biomarker Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Biomarker Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Biomarker Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Biomarker Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Biomarker Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Biomarker Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Biomarker Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Biomarker Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Biomarker Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Biomarker Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Biomarker Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Biomarker Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Biomarker Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Biomarker Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Biomarker Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Biomarker Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Biomarker Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Biomarker Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Biomarker Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Biomarker Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Biomarker Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Biomarker Market Size, 2019-2021 (US$ Million)
Table 57. QIAGEN N.V. (Netherlands) Business Overview
Table 58. QIAGEN N.V. (Netherlands) Biomarker Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. QIAGEN N.V. (Netherlands) Biomarker Product
Table 60. QIAGEN N.V. (Netherlands) Response to COVID-19 and Related Developments
Table 61. PerkinElmer, Inc. (U.S.) Business Overview
Table 62. PerkinElmer, Inc. (U.S.) Biomarker Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. PerkinElmer, Inc. (U.S.) Biomarker Product
Table 64. PerkinElmer, Inc. (U.S.) Response to COVID-19 and Related Developments
Table 65. Merck Millipore (U.S.) Business Overview
Table 66. Merck Millipore (U.S.) Biomarker Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Merck Millipore (U.S.) Biomarker Product
Table 68. Merck Millipore (U.S.) Response to COVID-19 and Related Developments
Table 69. Bio-Rad Laboratories, Inc. (U.S.) Business Overview
Table 70. Bio-Rad Laboratories, Inc. (U.S.) Biomarker Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Bio-Rad Laboratories, Inc. (U.S.) Biomarker Product
Table 72. Bio-Rad Laboratories, Inc. (U.S.) Response to COVID-19 and Related Developments
Table 73. Enzo Biochem, Inc. (U.S.) Business Overview
Table 74. Enzo Biochem, Inc. (U.S.) Biomarker Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Enzo Biochem, Inc. (U.S.) Biomarker Product
Table 76. Enzo Biochem, Inc. (U.S.) Response to COVID-19 and Related Developments
List of Figures
Figure 1. Biomarker Product Picture
Figure 2. Biomarker Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Biomarker Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Biomarker Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Biomarker Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Biomarker Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Biomarker Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Biomarker Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Biomarker Market Size Market Share, 2019-2021
Keyplayers in Covid-19 Impact on Biomarker Market, Global Research Reports 2020-2021
QIAGEN N.V. (Netherlands)PerkinElmer, Inc. (U.S.)
Merck Millipore (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Enzo Biochem, Inc. (U.S.)
Request Sample
Request Discount
